Bli medlem
Bli medlem

Du är här


Enea AB: Redeye: Enea - Next Growth Stratum

Redeye maintains its valuation and positive view of Enea, following
our estimate changes yesterday. Shares still trade at a meager 13X
EV/EBIT 21E. We raise our sight, beyond the Corona crisis, and expect
the Stratum deal of USD 15-20m to drive solid growth from 2021.

Read more and download the research update:

Start following companies at Redeye to receive the latest equity
research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment


Författare Cision News

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.